BRAF and colorectal carcinoma: V-raf murine sarcoma viral oncogene homolog B1 (BRAF), a principal downstream effector of the mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) pathway, is mutated in 5%–10% of colorectal cancer (CRC) cases [1].